Alison Tree 💙 (@alison

So honoured to have been part of the PACE team for the last 12 years. I have learned so much from @nickva1 @EmmaHall71 and the whole team. Thanks to the 874 men and over 30 hospitals who partnered with us and to Accuray for funding. Abstract here astro2023.eventscribe.net/index.asp?sess…

Alison Tree 💙

@alison_tree

Apr 6, 2020

In a world desperate for some good news, I am so proud to congratulate the awesome @AnnaKirby17 @royalmarsdenNHS @ICR_London on becoming President Elect of @ESTRO_RT Shame we can't all raise a glass in person, but hopefully soon...

Alison Tree 💙

@alison_tree

Sep 14, 2022

My first Tweetorial 🧵 2 year toxicity results of PACE B published here. Big thanks to the 🇬🇧🇨🇦 and🇮🇪collaborators and the 874 men with prostate cancer who made this trial possible

thelancet.com

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-...

In the PACE-B trial, 2-year RTOG toxicity rates were similar for five fraction SBRT and conventional schedules of radiotherapy. Prostate SBRT was found to be safe and associated with low rates of...

Alison Tree 💙

@alison_tree

Sep 14, 2022

PACE-B 2 year paper finally out! thelancet.com/journals/lanon… Tweetorial coming shortly, but firstly massive thanks to @nickva1 @EmmaHall71 @royalmarsdenNHS @royalmarsden @Accuray @VarianMedSys @ICR_CTSU @ProstateUK and many more, for support of the PACE umbrella

thelancet.com

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-...

In the PACE-B trial, 2-year RTOG toxicity rates were similar for five fraction SBRT and conventional schedules of radiotherapy. Prostate SBRT was found to be safe and associated with low rates of...

Alison Tree 💙

@alison_tree

May 3, 2020

One tiny silver lining of this tragedy is that, at present, winning Love Island is no longer seen as the pinnacle of achievement in the world, but instead people seem to value kindness, caring for others and bravery. Let’s hope that lasts.

Alison Tree 💙

@alison_tree

Dec 20, 2021

Despite another trying year, good to see our sense of humour is intact in the @RM_Radiotherapy Christmas decoration competition. Glad I don't need to choose between the Penguin Cyberknife and the MR Linac igloo! It is truly a privilege to work with you all. Merry Christmas.

Alison Tree 💙

@alison_tree

Jun 8, 2019

Oligoprogression: Treat the whole lawn or weed selectively? clinicaloncologyonline.net/article/S0936-… @drdavidpalma @fifimcdrmh @RCRadiologists Lots of exciting research ongoing including the TRAP trial (thanks to @ProstateUK) and the HALT trial (thanks to @CR_UK @ICR_CTSU)

Alison Tree 💙

@alison_tree

Feb 16, 2023

#PACE A showing more urinary incontinence than expected #GU23 Great presentation ⁦@nickva1⁩ and credit to whole team ⁦@royalmarsdenNHS⁩ ⁦@ICR_CTSU⁩ for running such a difficult trial

Alison Tree 💙

@alison_tree

Oct 23, 2022

Is this the end of 2Gy/ fraction for localised prostate cancer? I hope so. Dr Niazi presenting the PCS5 trial showing equivalent outcomes for mod hypofrac in high risk PCa #ASTRO22 #radonc

Alison Tree 💙

@alison_tree

Aug 8, 2023

A real honour to visit Tata Memorial hospital and to attend the SOGOCON23 conference, meeting many multi-disciplinary colleagues committed to improving uro-oncological care in India. And they are running so many amazing trials!

Alison Tree 💙

@alison_tree

Oct 19, 2022

Delighted that the first DELINEATE trial cohorts now published @IJROBP . 5yr bRFS 96.7% with boost to 67Gy in 20; toxicity similar to non-boost literature. Thanks to Prof Dearnaley who set this trial up in 2011! authors.elsevier.com/a/1fxC61Hx52CN… @juliarmurray @PCaParker @RM_Radiotherapy

Alison Tree 💙

@alison_tree

Jun 1, 2023

Shocking! Only 1.4% of global cancer spend is used for surgical research and only 2.8% on radiotherapy research. Please help us learn how to cure more patients by funding curative therapies research! #radonc

Richard Sullivan

@SullivanProf

Jun 1, 2023

The abysmal state of global research funding on key domains such as surgery, radiotherapy and health services. Combined less than 4%. How have research funding organisations managed to get their strategic priorities so wrong? ⁦@cspramesh⁩ ⁦ thelancet.com/journals/lanon…

Alison Tree 💙

@alison_tree

May 14, 2023

Great to see long term results from OLIGOPELVIS, seems likely that cure is a realistic option for some patients (maybe 1/3rd) with pelvic oligorecurrence #ESTRO23

Alison Tree 💙

@alison_tree

Dec 28, 2022

Delighted that we have achieved our accrual target for the TRAP trial this week clinicaltrials.gov/ct2/show/NCT03… funded by the amazing people @ProstateUK . Thanks to so many people who made this happen during a really tough few years! @RTTQA_UK @royalmarsdenNHS